176 related articles for article (PubMed ID: 24581929)
1. Presenting efficacy information in direct-to-consumer prescription drug advertisements.
O'Donoghue AC; Sullivan HW; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
Patient Educ Couns; 2014 May; 95(2):271-80. PubMed ID: 24581929
[TBL] [Abstract][Full Text] [Related]
2. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.
Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356
[TBL] [Abstract][Full Text] [Related]
3. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.
Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR
Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655
[TBL] [Abstract][Full Text] [Related]
4. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
[TBL] [Abstract][Full Text] [Related]
5. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.
Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ
Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947
[No Abstract] [Full Text] [Related]
7. Disease Information in Direct-to-Consumer Prescription Drug Print Ads.
Aikin KJ; Sullivan HW; Betts KR
J Health Commun; 2016; 21(2):228-39. PubMed ID: 26717304
[TBL] [Abstract][Full Text] [Related]
8. Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements.
Betts KR; Boudewyns V; Aikin KJ; Squire C; Dolina S; Hayes JJ; Southwell BG
Res Social Adm Pharm; 2018 Oct; 14(10):951-963. PubMed ID: 28844621
[TBL] [Abstract][Full Text] [Related]
9. Visual images of prescription drug benefits in direct-to-consumer television advertisements.
Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Amoozegar JB; Rupert DJ
Patient Educ Couns; 2021 Sep; 104(9):2240-2249. PubMed ID: 33618970
[TBL] [Abstract][Full Text] [Related]
10. Using a drug facts box to communicate drug benefits and harms: two randomized trials.
Schwartz LM; Woloshin S; Welch HG
Ann Intern Med; 2009 Apr; 150(8):516-27. PubMed ID: 19221371
[TBL] [Abstract][Full Text] [Related]
11. Randomized study of placebo and framing information in direct-to-consumer print advertisements for prescription drugs.
O'Donoghue AC; Sullivan HW; Aikin KJ
Ann Behav Med; 2014 Dec; 48(3):311-22. PubMed ID: 24682975
[TBL] [Abstract][Full Text] [Related]
12. Consumer friendly or reader hostile? An evaluation of the readability of DTC print ads.
Sheehan K
Health Mark Q; 2008; 23(4):1-16. PubMed ID: 19042509
[TBL] [Abstract][Full Text] [Related]
13. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.
Faerber AE; Kreling DH
J Gen Intern Med; 2014 Jan; 29(1):110-8. PubMed ID: 24030427
[TBL] [Abstract][Full Text] [Related]
14. Pharmacy students' knowledge, attitudes, and evaluation of direct-to-consumer advertising.
Naik RK; Borrego ME; Gupchup GV; Dodd M; Sather MR
Am J Pharm Educ; 2007 Oct; 71(5):86. PubMed ID: 17998983
[TBL] [Abstract][Full Text] [Related]
15. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
Adams C
J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
[TBL] [Abstract][Full Text] [Related]
16. "When diet and exercise are not enough": an examination of lifestyle change inefficacy claims in direct-to-consumer advertising.
Byrne S; Niederdeppe J; Avery RJ; Cantor J
Health Commun; 2013; 28(8):800-13. PubMed ID: 23444915
[TBL] [Abstract][Full Text] [Related]
17. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
Khanfar N; Loudon D; Sircar-Ramsewak F
Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
[TBL] [Abstract][Full Text] [Related]
18. The attitudes of consumers toward direct advertising of prescription drugs.
Morris LA; Brinberg D; Klimberg R; Rivera C; Millstein LG
Public Health Rep; 1986; 101(1):82-9. PubMed ID: 3080797
[TBL] [Abstract][Full Text] [Related]
19. Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease.
Eisenberg MD; Singh Y; Sood N
JAMA Health Forum; 2022 Aug; 3(8):e222570. PubMed ID: 36200632
[TBL] [Abstract][Full Text] [Related]
20. Consumer attitudes about advertisements for medicinal drugs.
Morris LA; Brinberg D; Klimberg R; Millstein L; Rivera C
Soc Sci Med; 1986; 22(6):629-38. PubMed ID: 3715502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
